Literature DB >> 6402238

Prevalence and treatment of gall stones after gastric bypass surgery for morbid obesity.

D A Wattchow, J C Hall, M J Whiting, B Bradley, J Iannos, J M Watts.   

Abstract

Entities:  

Mesh：

Year:  1983        PMID： 6402238      PMCID： PMC1547033          DOI： 10.1136/bmj.286.6367.763

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

Review 1.  Risk factors for the development of cholelithiasis in man (first of two parts).

Authors:  L J Bennion; S M Grundy
Journal:  N Engl J Med       Date:  1978-11-23       Impact factor: 91.245

2.  Precision and accuracy in the measurement of the cholesterol saturation index of duodenal bile. Lack of variation due to the menstrual cycle.

Authors:  M J Whiting; R H Down; J M Watts
Journal:  Gastroenterology       Date:  1981-03       Impact factor: 22.682

3.  Bilary lipid metabolism in obesity. Effects of bile acid feeding before and during weight reduction.

Authors:  H Y Mok; K von Bergmann; J R Crouse; S M Grundy
Journal:  Gastroenterology       Date:  1979-03       Impact factor: 22.682
  3 in total
  17 in total

Review 1.  Gastrointestinal complications of obesity surgery.

Authors:  John E Pandolfino; Brintha Krishnamoorthy; Thomas J Lee
Journal:  MedGenMed       Date:  2004-04-20

2.  Effect of genetic variants related to lipid metabolism as risk factors for cholelithiasis after bariatric surgery in Brazilian population.

Authors:  Sidney Pinheiro-Júnior; Marcela A S Pinhel; Marcelo A Nakazone; Anielli Pinheiro; Gisele F S Amorim; Greiciane M S Florim; Camila M Mazeti; Michele L Gregório; Marina G Moschetta; Gilberto B Brito; Sérgio L A Brienze; Carla B Nonino; Antonio C Brandão; Dorotéia R S Souza
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

3.  Early changes in postprandial gallbladder emptying in morbidly obese patients undergoing Roux-en-Y gastric bypass: correlation with the occurrence of biliary sludge and gallstones.

Authors:  Michel Bastouly; Carlos Haruo Arasaki; Jael Brasil Ferreira; Arnaldo Zanoto; Fabíola Gouveia H P Borges; José Carlos Del Grande
Journal:  Obes Surg       Date:  2008-08-12       Impact factor: 4.129

4.  Common bile duct dilation after bariatric surgery.

Authors:  Neal Mehta; Andrew T Strong; Tyler Stevens; Kevin El-Hayek; Alfred Nelson; Adeyinka Owoyele; Ahmed Eltelbany; Prabhleen Chahal; Maged Rizk; Carol A Burke; John McMichael; Rocio Lopez; Joseph Veniero; John Vargo; Matthew Kroh; Amit Bhatt
Journal:  Surg Endosc       Date:  2018-10-23       Impact factor: 4.584

5.  Gall stones in a Danish population. Relation to weight, physical activity, smoking, coffee consumption, and diabetes mellitus.

Authors:  T Jørgensen
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

6.  Cholecystoduodenal fistula in a patient post-Roux-en-Y gastric bypass.

Authors:  Brian C Hill; Leandra H Burke; Christian W Ertl
Journal:  BMJ Case Rep       Date:  2013-09-02

7.  Transgastric endoscopic retrograde cholangiopancreatography for the management of biliary tract disease after Roux-en-Y gastric bypass treatment for obesity.

Authors:  Marcelo Falcão; Josemberg Marins Campos; Manoel Galvão Neto; Almino Ramos; Thiago Secchi; Erivaldo Alves; Eduardo Franca; Fauze Maluf-Filho; Alvaro Ferraz
Journal:  Obes Surg       Date:  2012-06       Impact factor: 4.129

8.  Natural history and treatment with ursodiol of gallstones formed during rapid loss of weight in man.

Authors:  J W Marks; T Stein; L J Schoenfield
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

9.  Gallbladder motility and lithogenesis in obese patients during diet-induced weight loss.

Authors:  R Zapata; C Severín; M Manríquez; V Valdivieso
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

10.  A descriptive study of pregnant women with gallstones. Relation to dietary and social habits, education, physical activity, height, and weight.

Authors:  L Basso; P T McCollum; M R Darling; A Tocchi; W A Tanner
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.